Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Hepatocellular carcinoma screening practices in the Department of Veterans Affairs: findings from a national facility survey.

El-Serag HB, Alsarraj A, Richardson P, Davila JA, Kramer JR, Durfee J, Kanwal F.

Dig Dis Sci. 2013 Nov;58(11):3117-26. doi: 10.1007/s10620-013-2794-7. Epub 2013 Jul 19.

2.

Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.

Davila JA, Henderson L, Kramer JR, Kanwal F, Richardson PA, Duan Z, El-Serag HB.

Ann Intern Med. 2011 Jan 18;154(2):85-93. doi: 10.7326/0003-4819-154-2-201101180-00006.

PMID:
21242365
3.

The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.

El-Serag HB, Richardson PA, Everhart JE.

Am J Gastroenterol. 2001 Aug;96(8):2462-7.

PMID:
11513191
4.

Hepatitis B and hepatocellular carcinoma screening among Asian Americans: survey of safety net healthcare providers.

Khalili M, Guy J, Yu A, Li A, Diamond-Smith N, Stewart S, Chen M Jr, Nguyen T.

Dig Dis Sci. 2011 May;56(5):1516-23. doi: 10.1007/s10620-010-1439-3. Epub 2010 Nov 3.

5.

Quality of Care Provided by Hepatologists to Patients with Cirrhosis at Three Parallel Health Systems.

Sclair SN, Carrasquillo O, Czul F, Trivella JP, Li H, Jeffers L, Martin P.

Dig Dis Sci. 2016 Oct;61(10):2857-2867. doi: 10.1007/s10620-016-4221-3. Epub 2016 Jun 11.

PMID:
27289585
6.

Referral and receipt of treatment for hepatocellular carcinoma in United States veterans: effect of patient and nonpatient factors.

Davila JA, Kramer JR, Duan Z, Richardson PA, Tyson GL, Sada YH, Kanwal F, El-Serag HB.

Hepatology. 2013 May;57(5):1858-68. doi: 10.1002/hep.26287. Epub 2013 Mar 14.

7.

Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey.

Chalasani N, Said A, Ness R, Hoen H, Lumeng L.

Am J Gastroenterol. 1999 Aug;94(8):2224-9.

PMID:
10445554
8.

A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.

Zhang JY, Dai M, Wang X, Lu WQ, Li DS, Zhang MX, Wang KJ, Dai LP, Han SG, Zhou YF, Zhuang H.

Int J Epidemiol. 1998 Aug;27(4):574-8.

PMID:
9758109
9.

Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: a modeling approach.

Mourad A, Deuffic-Burban S, Ganne-CarriƩ N, Renaut-Vantroys T, Rosa I, Bouvier AM, Launoy G, Cattan S, Louvet A, Dharancy S, Trinchet JC, Yazdanpanah Y, Mathurin P.

Hepatology. 2014 Apr;59(4):1471-81. doi: 10.1002/hep.26944. Epub 2014 Feb 25.

PMID:
24677195
10.

Risk profile of hepatocellular carcinoma reveals dichotomy among US veterans.

Karagozian R, Baker E, Houranieh A, Leavitt D, Baffy G.

J Gastrointest Cancer. 2013 Sep;44(3):318-24. doi: 10.1007/s12029-013-9499-1.

PMID:
23609167
11.

Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population.

Mittal S, Sada YH, El-Serag HB, Kanwal F, Duan Z, Temple S, May SB, Kramer JR, Richardson PA, Davila JA.

Clin Gastroenterol Hepatol. 2015 Mar;13(3):594-601.e1. doi: 10.1016/j.cgh.2014.08.013. Epub 2014 Aug 19.

12.

Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.

Beste LA, Leipertz SL, Green PK, Dominitz JA, Ross D, Ioannou GN.

Gastroenterology. 2015 Nov;149(6):1471-1482.e5; quiz e17-8. doi: 10.1053/j.gastro.2015.07.056. Epub 2015 Aug 5.

PMID:
26255044
13.

Hepatocellular carcinoma and hepatitis C in the United States.

El-Serag HB.

Hepatology. 2002 Nov;36(5 Suppl 1):S74-83. Review.

PMID:
12407579
14.

Low adherence of HIV providers to practice guidelines for hepatocellular carcinoma screening in HIV/hepatitis B coinfection.

Hearn B, Chasan R, Bichoupan K, Suprun M, Bagiella E, Dieterich DT, Perumalswami P, Branch AD, Huprikar S.

Clin Infect Dis. 2015 Dec 1;61(11):1742-8. doi: 10.1093/cid/civ654. Epub 2015 Aug 3.

15.

Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.

El-Serag HB, Kramer J, Duan Z, Kanwal F.

Am J Gastroenterol. 2014 Sep;109(9):1427-35. doi: 10.1038/ajg.2014.214. Epub 2014 Jul 29.

PMID:
25070058
16.

[The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].

Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH.

Korean J Hepatol. 2008 Mar;14(1):67-76. doi: 10.3350/kjhep.2008.14.1.67. Korean.

17.

Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.

Thein HH, Walter SR, Gidding HF, Amin J, Law MG, George J, Dore GJ.

J Viral Hepat. 2011 Jul;18(7):e232-41. doi: 10.1111/j.1365-2893.2011.01440.x. Epub 2011 Feb 17.

PMID:
21692938
18.

Current status of hepatitis C virus infection in Korea.

Suh DJ, Jeong SH.

Intervirology. 2006;49(1-2):70-5. Review.

PMID:
16166792
19.

A population approach to disease management: hepatitis C direct-acting antiviral use in a large health care system.

Belperio PS, Backus LI, Ross D, Neuhauser MM, Mole LA.

J Manag Care Spec Pharm. 2014 Jun;20(6):533-40.

20.

Hepatitis C and hepatocellular carcinoma.

Yao F, Terrault N.

Curr Treat Options Oncol. 2001 Dec;2(6):473-83. Review.

PMID:
12057093

Supplemental Content

Support Center